Dr Reddy''s Laboratories Ltd has expanded its presence
in Africa with the opening of its 40th overseas office
in Lagos , Nigeria in partnership with Phillips Pharmaceuticals.
This distributor-based model will serve the $280 million
Nigerian pharmaceutical market, DRL said in filing with
the Bombay Stock Exchange (BSE).
company is initially targeting therapeutic areas tike
gastroenterology, diabetes and cancer. The first phase
of launch will see major brands like Omez, Reclide, Diavista,
Osetron and Docetere 20mg (from amongst the range of oncology
drugs) being introduced in the Nigerian market.
are committed to bringing quality and affordable medicine
to people across the world and the initiation of our Nigerian
operations is one more step in that direction. With the
introduction of our leading brands, we are extremely confident
of making our presence felt among the Nigerian medical
community," Rajesh Kumar, head-AMEEERA region of
manufactures and markets API (bulk actives), finished
dosages and biologics in over 100 countries worldwide,
in addition to having a very promising drug discovery
pipeline. The drug maker currently operates across the
US, the UK, Russia , China, Sri Lanka , Kazakhstan, Kazakhstan
company registered a net profit of $ 1,510 million in
FY''07, of which international revenue accounted for 86
per cent or $1,297 million.